SBGneuro Ltd. brings together leading neuro-imaging experts to enable functional and structural MRI to fulfil its rich potential as a powerful, non-invasive biomarker for a wide range of diseases and disease treatments. We offer expertise in basic image acquisition methodology, imaging data analysis, and clinical neuroscience. Our services include pre-trial consulting, study design and acquisition optimization, definition of a priori outcome measures, data quality control, integrated functional and structural data analysis, post-trial interpretation, and dissemination of results.
In the first phases of PRISM 2, SBGneuro will work with project partner Cohen Veterans Bioscience Inc. (CVB) to focus on the management of existing study data, developing a data sustainability plan, and supervision of first-level magnetic resonance imaging (MRI) endpoints. In next-level analyses, we will test the reproducibility and generalisability of PRISM endpoints across disorders.